Skip to the content
NeuroDex – Biomarkers for Neurological Disorderslogo darklogo light
  • About Us
    • Our Team
    • Our Labs
    • Why NeuroDex
  • Our Tech
    • ExoSORT™ Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • Pre-Clinical Services
    • Clinical Trial Services
    • Pharmacodynamic Biomarkers
    • Cognilera® Panel for Trials
  • Applications
    • Alzheimer’s
    • Parkinson’s & Synucleinopathies
    • ALS & FTD
  • Resources
    • Learn
    • Alzheimer’s
    • Parkinson’s & Lewy Body
    • ALS & FTD
    • Methods
    • Regulatory & Trial Design
    • NeuroDex News
    • Biotech Blog
    • White Papers
    • NeuroDex Brochures
  • Contact Us

NeuroDex – Biomarkers for Neurological Disorderslogo darklogo light
HomePosted by Victoria Akhiezer(Page 6)
NeuroDex Pioneers New Multi-Pronged Biomarker for Neurodegenerative Diseases
NeuroDex News

NeuroDex Pioneers New Multi-Pronged Biomarker for Neurodegenerative Diseases

Victoria Akhiezer
November 12, 2024
Target ALS
NeuroDex News

NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research

Victoria Akhiezer
November 7, 2024
Dr. Erez Eitan to Participate in the Alzheimer’s Association International Conference (AAIC) 2024
NeuroDex News

Dr. Erez Eitan to Participate in the Alzheimer’s Association International Conference (AAIC) 2024

Victoria Akhiezer
July 25, 2024
NeuroDex at the Bio-Neuroscience Conference
NeuroDex News

NeuroDex at the Bio-Neuroscience Conference

Victoria Akhiezer
February 5, 2024
NeuroDex Announces Second Award from The Michael J. Fox Foundation
NeuroDex News

NeuroDex Announces Second Award from The Michael J. Fox Foundation

Victoria Akhiezer
November 3, 2023
NeuroDex to Participate in 2nd Annual AAEV Meeting: Exploring the Potential of Extracellular Vesicles
NeuroDex News

NeuroDex to Participate in 2nd Annual AAEV Meeting: Exploring the Potential of Extracellular Vesicles

Victoria Akhiezer
October 26, 2023
NeuroDex’s Chief Scientific Officer, Dr. Erez Eitan to Speak on Groundbreaking Biomarker Research at ISEV Workshop
NeuroDex News

NeuroDex’s Chief Scientific Officer, Dr. Erez Eitan to Speak on Groundbreaking Biomarker Research at ISEV Workshop

Victoria Akhiezer
October 9, 2023
Parkinson's disease
NeuroDex News

Michael J. Fox Foundation Funds Research on a Potential Parkinson’s Biomarker

Victoria Akhiezer
April 24, 2023
NeuroDex, Inc., Announces Award from Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator
NeuroDex News

NeuroDex, Inc., Announces Award from Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator

Victoria Akhiezer
March 28, 2023
NeuroDex Presents Breakthrough Research on Exosomes for Neurodegenerative Disease Diagnosis at 'Extracellular Vesicles: Friends and Foes II' Congress
NeuroDex News

NeuroDex Presents Breakthrough Research on Exosomes for Neurodegenerative Disease Diagnosis at ‘Extracellular Vesicles: Friends and Foes II’ Congress

Victoria Akhiezer
March 24, 2023

Posts pagination

1 2 3 4 5 6 7

Contact Us

Company

NeuroDex Inc

  • 22 Strathmore Road
  • Natick, MA US 01760
  • info@neurodex.co
Information
  • Terms & Conditions
  • Privacy Policy
  • NeuroDex FAQ
Resources
  • Explanation Material
  • NeuroDex News
  • Blog
Back to top Drag
  • About Us
    • Our Team
    • Our Labs
    • Why NeuroDex
  • Our Tech
    • ExoSORT™ Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • Pre-Clinical Services
    • Clinical Trial Services
    • Pharmacodynamic Biomarkers
    • Cognilera® Panel for Trials
  • Applications
    • Alzheimer’s
    • Parkinson’s & Synucleinopathies
    • ALS & FTD
  • Resources
    • Learn
    • Alzheimer’s
    • Parkinson’s & Lewy Body
    • ALS & FTD
    • Methods
    • Regulatory & Trial Design
    • NeuroDex News
    • Biotech Blog
    • White Papers
    • NeuroDex Brochures
  • Contact Us
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}